Curevac Kemula News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Curevac kemula. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Curevac Kemula Today - Breaking & Trending Today
The next generation Covid-19 vaccines seeking a slice of the market A new group of vaccine makers is hoping to challenge the Covid-19 shots that are already household names, sharpening competition in what is set to be the first ever jab market to encompass the entire global population. BioNTech/Pfizer and Moderna, the pandemic’s mRNA-based vaccine frontrunners, have already booked billions of dollars in revenue, which they are using to boost production, sign new contracts and entrench their positions. Likewise, Oxford/AstraZeneca and Johnson & Johnson have been rolling out their cheaper and easier to transport shots for months, while Chinese and Russian-made vaccines dominate in several markets. ....
Dive Brief: German drug conglomerate Bayer will help CureVac manufacture tens of millions more doses of the biotech s experimental coronavirus vaccine beginning as soon as the end of this year, company executives said in a Monday briefing with the German health minister. Bayer and CureVac are already co-developing the vaccine, with the large pharma providing support for clinical testing and regulatory discussions in other countries. Now, after discussions with the German government, Bayer has also agreed to make 160 million doses of CureVac s shot in 2022 CureVac recently began a Phase 2/3 study testing whether its vaccine prevents COVID-19. The company aims to enroll into the trial some 36,000 volunteers in Europe and South America. Early results could be available by the end of March, CureVac s CFO Pierre Kemula recently told BioPharma Dive. ....